Works matching IS 15228517 AND DT 2021 AND VI 23 AND IP 11
Results: 27
Single-cell transcriptome and genome analysis: A much-needed tool for pituitary neuroendocrine tumor studies.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 11, p. 1803, doi. 10.1093/neuonc/noab205
- By:
- Publication type:
- Article
Highlights from the Literature.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 11, p. 1818, doi. 10.1093/neuonc/noab237
- Publication type:
- Article
Forthcoming Meetings.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 11, p. 1987, doi. 10.1093/neuonc/noab236
- Publication type:
- Article
evolving role of systemic therapy and local, brain-directed treatment in patients with melanoma and brain metastases.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 11, p. 1816, doi. 10.1093/neuonc/noab194
- By:
- Publication type:
- Article
Short reply to "Proton therapy for newly diagnosed glioblastoma: more room for investigation" by R. Press et al.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 11, p. 1982, doi. 10.1093/neuonc/noab193
- By:
- Publication type:
- Article
Hypermutated recurrences: Identifying the clinical relevance.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 11, p. 1805, doi. 10.1093/neuonc/noab192
- By:
- Publication type:
- Article
Reply to: "Assessment of imaging biomarkers in the follow-up of brain metastases after SRS".
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 11, p. 1985, doi. 10.1093/neuonc/noab191
- By:
- Publication type:
- Article
COVID-19 in pediatric cancer: Where are the brain tumors?
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 11, p. 1977, doi. 10.1093/neuonc/noab189
- By:
- Publication type:
- Article
Cannabinoids and NF-κB: Hijacking a pro-cancer signal Can Be Done.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 11, p. 1810, doi. 10.1093/neuonc/noab187
- By:
- Publication type:
- Article
Silencing glioblastoma networks to make temozolomide more effective.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 11, p. 1807, doi. 10.1093/neuonc/noab186
- By:
- Publication type:
- Article
Diffuse hemispheric glioma, H3 G34-mutant: Genomic landscape of a new tumor entity and prospects for targeted therapy.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 11, p. 1974, doi. 10.1093/neuonc/noab184
- By:
- Publication type:
- Article
early foray with targeted therapy and inspiring novel approaches to combat adult medulloblastoma.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 11, p. 1814, doi. 10.1093/neuonc/noab179
- By:
- Publication type:
- Article
EANO guideline on the diagnosis and management of meningiomas.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 11, p. 1821, doi. 10.1093/neuonc/noab150
- By:
- Publication type:
- Article
Rethinking immunotherapy in meningiomas.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 11, p. 1812, doi. 10.1093/neuonc/noab168
- By:
- Publication type:
- Article
Targeting the CSF1/CSF1R axis is a potential treatment strategy for malignant meningiomas.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 11, p. 1922, doi. 10.1093/neuonc/noab075
- By:
- Publication type:
- Article
Assessment of imaging biomarkers in the follow-up of brain metastases after SRS.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 11, p. 1983, doi. 10.1093/neuonc/noab160
- By:
- Publication type:
- Article
SNO and EANO practice guideline update: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 11, p. 1835, doi. 10.1093/neuonc/noab152
- By:
- Publication type:
- Article
SNO 2020 diversity survey: defining demographics, racial biases, career success metrics and a path forward for the field of neuro-oncology.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 11, p. 1845, doi. 10.1093/neuonc/noab172
- By:
- Publication type:
- Article
Proton therapy for newly diagnosed glioblastoma: more room for investigation.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 11, p. 1980, doi. 10.1093/neuonc/noab139
- By:
- Publication type:
- Article
immune-competent, replication-permissive Syrian Hamster glioma model for evaluating Delta-24-RGD oncolytic adenovirus.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 11, p. 1911, doi. 10.1093/neuonc/noab128
- By:
- Publication type:
- Article
Newly established patient-derived organoid model of intracranial meningioma.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 11, p. 1936, doi. 10.1093/neuonc/noab155
- By:
- Publication type:
- Article
Single-cell transcriptome and genome analyses of pituitary neuroendocrine tumors.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 11, p. 1859, doi. 10.1093/neuonc/noab102
- By:
- Publication type:
- Article
Safety and efficacy of the combination of nivolumab plus ipilimumab in patients with melanoma and asymptomatic or symptomatic brain metastases (CheckMate 204).
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 11, p. 1961, doi. 10.1093/neuonc/noab094
- By:
- Publication type:
- Article
Meclofenamate causes loss of cellular tethering and decoupling of functional networks in glioblastoma.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 11, p. 1885, doi. 10.1093/neuonc/noab092
- By:
- Publication type:
- Article
MEVITEM—a phase I/II trial of vismodegib + temozolomide vs temozolomide in patients with recurrent/refractory medulloblastoma with Sonic Hedgehog pathway activation.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 11, p. 1949, doi. 10.1093/neuonc/noab087
- By:
- Publication type:
- Article
Temozolomide-induced hypermutation is associated with distant recurrence and reduced survival after high-grade transformation of low-grade IDH-mutant gliomas.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 11, p. 1872, doi. 10.1093/neuonc/noab081
- By:
- Publication type:
- Article
Cannabidiol converts NF-κB into a tumor suppressor in glioblastoma with defined antioxidative properties.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 11, p. 1898, doi. 10.1093/neuonc/noab095
- By:
- Publication type:
- Article